Abstract
The prevalence of hypertension in individuals with obesity or type II diabetes is substantially elevated. Increased levels of non-esterified fatty acids (NEFAs) in abdominally obese subjects were reported to contribute in the development of various disturbances related to the metabolic syndrome, such as hepatic and peripheral insulin resistance (IR), dyslipidaemia, β-cell apoptosis, endothelial dysfunction and others. However, the involvement of NEFAs in the development of hypertension has been much less studied in comparison to other mechanisms linking IR and central obesity with blood pressure (BP) elevation. This article reviews the existing evidence on the relation between NEFA and hypertension in an attempt to shed a light on it. In vivo data from both animal and human studies support that acute plasma NEFA elevation leads to increase in BP levels, whereas epidemiological evidence suggests a link between increased NEFA levels and hypertension. Further, accumulating data indicate the existence of several pathways through which NEFAs could promote BP elevation, that is α1-adrenergic stimulation, endothelial dysfunction, increase in oxidant stress, stimulation of vascular cell's growth and others. The above data support a possible important role of NEFA in hypertension development in patients with obesity and the metabolic syndrome and raise hypotheses for future research.
Similar content being viewed by others
References
Reaven GM . Banting Lecture 1988. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595–1607.
Sarafidis PA, Nilsson PM . The metabolic syndrome: a glance in its history. J Hypertens 2006; 24: 621–626.
Kaplan NM . The deadly quartet. Upper body obesity, glucose intolerance, hypertriglyceridemia and hypertension. Arch Intern Med 1989; 149: 1514–1520.
Wajchenberg BL . Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 2000; 21: 697–738.
Jensen MD, Haymond MW, Rizza RA, Cryer PE, Miles JM . Influence of body fat distribution on free fatty acid metabolism in obesity. J Clin Invest 1989; 83: 1168–1173.
Martin ML, Jensen MD . Effects of body fat distribution on regional lipolysis in obesity. J Clin Invest 1991; 88: 609–613.
Bevilacqua S, Bonadonna R, Buzzigoli G, Boni C, Ciociaro D, Maccari F et al. Acute elevation of free fatty acid levels leads to hepatic insulin resistance in obese subjects. Metabolism 1987; 36: 502–506.
Boden G, Chen X, Ruiz J, White JV, Rosseti L . Mechanisms of fatty acid-induced inhibition of glucose uptake. J Clin Invest 1994; 93: 2438–2446.
Shimabukuro M, Zhou YT, Levi M, Unger R . Fatty acid-induced β cell apoptosis: a link between obesity and diabetes. Proc Natl Acad Sci USA 1998; 95: 2498–2502.
Steinberg HO, Baron AD . Vascular function, insulin resistance and fatty acids. Diabetologia 2002; 45: 623–634.
Nilsson L, Banfi C, Diczfalusy U, Tremoli E, Hamsten A, Eriksson P . Unsaturated fatty acids increase plasminogen activator inhibitor-1 in endothelial cells. Arterioscler Thromb Vasc Biol 1998; 18: 1679–1685.
Abate N . Obesity and Cardiovascular disease. Pathogenic role of the metabolic syndrome and therapeutic implications. J Diabetes Complications 2000; 14: 154–174.
Sarafidis PA, Lasaridis AN . Actions of PPARγ agonists explaining a possible blood pressure lowering effect. Am J Hypertens 2006; 19: 646–653.
Rocchini AP . Obesity hypertension. Am J Hypertens 2002; 15: 50S–52S.
Sharma AM, Engeli S, Pischon T . New developments in mechanisms of obesity-induced hypertension: role of adipose tissue. Curr Hypertens Rep 2001; 3: 152–156.
Egan BM, Greene EL, Goodfriend TL . Nonesterified fatty acids in blood pressure control and cardiovascular complications. Curr Hypertens Rep 2001; 3: 107–116.
Bulow J, Madsen J, Hojgaard L . Reversibility of the effects on local circulation of high lipid concentrations in blood. Scand J Clin Lab Invest 1990; 50: 291–296.
Meng HC, Edgren B . Source of plasma free fatty acids in dogs receiving fat emulsion and heparin. Am J Physiol 1963; 204: 691–695.
Grekin RJ, Vollmer AP, Sider RS . Pressor effects of portal venous oleate infusion. A proposed mechanism for obesity hypertension. Hypertension 1995; 26: 193–198.
Grekin RJ, Dumont CJ, Vollmer AP, Watts SW, Webb RC . Mechanisms in the pressor effects of hepatic portal venous fatty acid infusion. Am J Physiol 1997; 273: R324–R330.
Egan BM, Hennes MMI, Stepniakowski KT, O'Shaughnessy IM, Kissebach AH, Goodfriend TL . Obesity hypertension is related more to insulin's fatty acid than glucose action. Hypertension 1996; 27: 723–728.
Fagot-Campagna A, Balkau B, Simon D, Warnet JM, Claude JR, Ducimetiere P et al. High free fatty acid concentration: an independent risk factor for hypertension in the Paris Prospective Study. Int J Epidemiol 1998; 27: 808–813.
Steinberg HO, Tarshoby M, Monestel R, Hook G, Cronin J, Johnson A et al. Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation. J Clin Invest 1997; 100: 1230–1239.
Steinberg HO, Paradisi G, Hook G, Crowder K, Cronin J, Baron AD . Free fatty acid elevation impairs insulin-mediated vasodilation and nitric oxide production. Diabetes 2000; 49: 1231–1238.
Stojiljkovic MP, Zhang D, Lopes HF, Lee CG, Goodfriend TL, Egan BM . Hemodynamic effects of lipids in humans. Am J Physiol Regul Integr Comp Physiol 2001; 280: R1674–R1679.
Lopes HF, Stojiljkovic MP, Zhang D, Goodfriend TL, Egan BM . The pressor response to acute hyperlipidemia is enhanced in lean normotensive offspring of hypertensive parents. Am J Hypertens 2001; 14: 1032–1037.
Lopes HF, Martin KL, Nashar K, Morrow JD, Goodfriend TL, Egan BM . DASH diet lowers blood pressure and lipid-induced oxidative stress in obesity. Hypertension 2003; 41: 422–430.
Egan BM, Panis R, Hinderliter A, Shork N, Julius S . Mechanism of increased alpha-adrenergic vasoconstriction in human essential hypertension. J Clin Invest 1987; 80: 812–817.
Egan BM, Shork NJ, Weder AB . Regional hemodynamic abnormalities in overweight men: focus on α-adrenergic vascular responses. Am J Hypertens 1989; 2: 428–434.
Stepniakowski KT, Egan BM . Additive effects of hypertension and obesity to limit venous distensibility. Am J Physiol 1995; 268: R562–R568.
Neahring JM, Stepniakowski K, Greene AS, Egan BM . Insulin does not reduce forearm alpha-vasoreactivity in obese hypertensive or lean normotensive men. Hypertension 1993; 22: 584–590.
Stepniakowski KT, Goodfriend TL, Egan BM . Fatty acids enhance vascular α-adrenergic sensitivity. Hypertension 1995; 25: II774–II778.
Stepniakowski KT, Sallee FR, Goodfriend TL, Zhang Z, Egan BM . Fatty acids enhance neurovascular reflex responses by effects on alpha 1-adrenoceptors. Am J Physiol 1996; 270: R1340–R1346.
Haastrup AT, Stepniakowski KT, Goodfriend TL, Egan BM . Intralipid enhances alpha1-adrenergic receptor mediated pressor sensitivity. Hypertension 1998; 32: 693–698.
Lundman P, Eriksson M, Schenck-Gustafsson K, Karpe F, Tornvall P . Transient triglyceridemia decreases vascular reactivity in young, healthy men without risk factors for coronary heart disease. Circulation 1997; 96: 3266–3268.
Davda RK, Stepniakowski KT, Lu G, Ullian ME, Goodfriend TL, Egan BM . Oleic acid inhibits endothelial cell nitric oxide synthase by a PKC-independent mechanism. Hypertension 1995; 26: 764–770.
Gupta MP, Steinberg H, Baron A, Hart CM . Fatty acids impair nitric oxide production in cultured endothelial cells [Abstract]. J Investig Med 1998; 46: 288A.
de Kreutzenberg SV, Crepaldi C, Marchetto S, Calo L, Tiengo A, Del Prato S et al. Plasma free fatty acids and endothelium-dependent vasodilation: effect of chain-length and cyclooxygenase inhibition. J Clin Endocrinol Metab 2000; 85: 793–798.
Scherrer U, Randin D, Vollenweider P, Vollenweider L, Nicod P . Nitric oxide release accounts for insulin's vascular effects in humans. J Clin Invest 1994; 94: 2511–2515.
Steinberg HO, Brechtel G, Johnson A, Fineberg N, Baron AD . Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent: a novel action of insulin to increase nitric oxide release. J Clin Invest 1994; 94: 1172–1179.
Steinberg HO, Chaker H, Leaming R, Johnson A, Brechtel G, Baron AD . Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest 1996; 97: 2601–2610.
Laine H, Knuuti MJ, Ruotsalainen U, Raitakari M, Iida H, Kapanen J et al. Insulin resistance in essential hypertension is characterized by impaired insulin stimulation of blood flow in skeletal muscle. J Hypertens 1998; 16: 211–219.
Sartori C, Scherrer U . Insulin, nitric oxide and the sympathetic nervous system: at the crossroads of metabolic and cardiovascular regulation. J Hypertens 1999; 17: 1517–1525.
Shepherd PR, Wither DJ, Siddle K . Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling. Biochem J 1998; 333: 471–490.
Zeng G, Quon MJ . Insulin-stimulated production of nitric oxide is inhibited by wortmannin: direct measurement in vascular endothelial cells. J Clin Invest 1996; 98: 894–898.
Roden M, Price TB, Perseghin G, Petersen KF, Rothman DL, Cline GW et al. Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest 1996; 97: 2859–2865.
Dresner A, Laurent D, Marcucci M, Griffin ME, Dufour S, Cline GW et al. Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. J Clin Invest 1999; 103: 253–259.
Lu G, Greene EL, Nagai T, Egan BM . Reactive oxygen species are critical in the oleic acid-mediated mitogenic signaling pathway in vascular smooth muscle cells. Hypertension 1998; 32: 1003–1010.
Stojiljkovic MP, Lopes HF, Zhang D, Morrow JD, Goodfriend TL, Egan BM . Increasing plasma fatty acids elevates F2-isoprostanes in humans: implications for the cardiovascular risk factor cluster. J Hypertens 2002; 20: 1215–1221.
Lopes HF, Morrow JD, Stojiljkovic MP, Goodfriend TL, Egan BM . Acute hyperlipidemia increases oxidative stress more in African Americans than in white Americans. Am J Hypertens 2003; 16: 331–336.
Nosratola D, Vaziri D, Wang XQ, Oveisi F, Rad B . Induction of oxidative stress by glutathione depletion causes severe hypertension in normal rats. Hypertension 2000; 36: 142–146.
Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM et al. A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med 1997; 336: 1117–1124.
Kaplan NM . Primary hypertension: pathogenesis. In: Kaplan NM (ed). Clinical Hypertension, 8th edn. Lippincott Williams & Wilkins: Philadelphia, PA, 2002, pp 56–135.
Lever AF, Harrap SB . Essential hypertension: a disorder of growth with origins in childhood? J Hypertens 1992; 10: 101–120.
Lu G, Morinelli TA, Meier KE, Rosenzweig SA, Egan BM . Oleic acid-induced mitogenic signaling in vascular smooth muscle cells. A role for protein kinase C. Circ Res 1996; 79: 611–618.
Lu G, Meier KE, Jaffa AA, Rosenzweig SA, Egan BM . Oleic acid and angiotensin induce a synergistic mitogenic response. Hypertension 1998; 31: 978–985.
Greene EL, Lu G, Zhang D, Egan BM . Signaling events mediating the additive effects of oleic acid and angiotensin II on vascular smooth muscle cell migration. Hypertension 2001; 37: 308–312.
Khan WA, Blobe G, Halpern A, Wetsel WC, Burns D, Loomis C et al. Selective regulation of protein kinase C isoezymes by oleic acid in human platelets. J Biol Chem 1993; 268: 5063–5068.
Berra E, Diaz-Meco MT, Dominguez I, Municio MM, Sanz L, Lozano J et al. Protein kinase C-z is critical for mitogenic signal transduction. Cell 1993; 74: 555–563.
Liao D-F, Monia B, Dean N, Berk BC . Protein kinase C-z mediates angiotensin II activation of ERK-1 and -2 in vascular smooth muscle cells. J Biol Chem 1997; 272: 6146–6150.
Askari B, Carroll MA, Capparelli M, Kramer F, Gerrity RG, Bornfeldt KE . Oleate and linoleate enhance the growth-promoting effects of insulin-like growth factor-I through a phospholipase D-dependent pathway in arterial smooth muscle cells. J Biol Chem 2002; 277: 36338–36344.
Sowers JR . Insulin and insulin-like growth factor in normal and pathological cardiovascular physiology. Hypertension 1997; 29: 691–699.
Safonova I, Aubert J, Negrel R, Ailhaud G . Regulation by fatty acids of angiotensinogen gene expression in preadipose cells. Biochem J 1997; 322: 235–239.
Goodfriend TL, Ball DL, Egan BM, Campbell WB, Nithipatikom K . Epoxy-keto derivative of linoleic acid stimulates aldosterone secretion. Hypertension 1004; 43: 358–363.
Tamura M, Kuwano H, Kinoshita T, Inagami T . Identification of linoleic and oleic acids as endogenous Na+,K+-ATPase inhibitors from acute volume-expanded hog plasma. J Biol Chem 1985; 260: 9672–9677.
Ng LL, Hockaday TD . Non-esterified fatty acids may regulate human leucocyte sodium pump activity. Clin Sci (London) 1986; 71: 737–742.
Lijnen P . Alterations in sodium metabolism as an etiological model for hypertension. Cardiovasc Drugs Ther 1995; 9: 377–399.
Sowers JR, Whitfield L, Beck FW, Catania RA, Tuck ML, Dornfeld L et al. Role of enhanced sympathetic nervous system activity and reduced Na+,K+-dependent adenosine triphosphatase activity in the maintenance of elevated blood pressure in obesity: effects of weight loss. Clin Sci 1982; 63: 121S–124S.
Weder AB . Sodium metabolism, hypertension and diabetes. Am J Med Sci 1994; 307: S53–S59.
Acknowledgements
This paper was not supported by any source and represents an original effort on our part.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sarafidis, P., Bakris, G. Non-esterified fatty acids and blood pressure elevation: a mechanism for hypertension in subjects with obesity/insulin resistance?. J Hum Hypertens 21, 12–19 (2007). https://doi.org/10.1038/sj.jhh.1002103
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.jhh.1002103
- Springer Nature Limited
Keywords
This article is cited by
-
Relation of insulin treatment for type 2 diabetes to the risk of major adverse cardiovascular events after acute coronary syndrome: an analysis of the BETonMACE randomized clinical trial
Cardiovascular Diabetology (2021)
-
Exploratory serum fatty acid patterns associated with blood pressure in community-dwelling middle-aged and elderly Chinese
Lipids in Health and Disease (2016)
-
Sex-related differences in the associations between plasma free fatty acid levels and clinical features in patients with hypertrophic cardiomyopathy
Biology of Sex Differences (2016)
-
Genetic relationship between an endothelin 1 gene polymorphism and lead-related high blood pressure
Molecular & Cellular Toxicology (2016)
-
Resistin - the link between adipose tissue dysfunction and insulin resistance in patients with obstructive sleep apnea
Journal of Diabetes & Metabolic Disorders (2013)